logo

For the Inventor, By the Inventor

Tokyo, Japan

Keijiro Ishibashi

This inventor holds 10 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keijiro Ishibashi. Retrieved from https://idiyas.com/inventor/keijiro-ishibashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 146(Granted Patents)


Location History:

  • Tokyo, JA (1976)
  • Hiro, JA (1976)
  • Tokyo, J (1976)
  • Tokyo, JP (1978 - 1979)

Company Filing History:

goldMedal10 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1976-1979

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4159317 - Method for preventing alveolar pyorrhea (1979-06-26),
2. 4107291 - Compositions for cleaning teeth and oral cavity (1978-08-15),
3. 3998699 - Antibiotic substances B-41, their production and their use as (1976-12-21),
4. 3992552 - Antibiotic substance B-41, their production and their use as (1976-11-16),
5. 3992551 - Antisiotic substances B-41, their production and their use as (1976-11-16),
6. 3992527 - Antibiotic substances B-41, their production and their use as (1976-11-16),
7. 3984564 - Antibiotic substances B-41, their production and their use as (1976-10-05),
8. 3974291 - Fungicidal compositions for dermatomycosis of animals (1976-08-10),
9. 3966914 - Antibiotic substances B-41, their production and their use as (1976-06-29),
10. 3950360 - Antibiotic substances (1976-04-13),

Title: The Innovative Genius of Keijiro Ishibashi

Introduction

Keijiro Ishibashi, a prominent inventor hailing from Tokyo, Japan, has made remarkable contributions to the field of dental care. With a total of nine patents under his name, Ishibashi is dedicated to creating effective solutions that enhance oral health and hygiene. His work, particularly at Sankyo Company, Limited, reflects a commitment to innovation and a deep understanding of dental science.

Latest Patents

Among his latest patents, Ishibashi has developed a method for preventing alveolar pyorrhea through compositions that contain a fructan-degrading enzyme. The invention describes the specific ratio of enzyme activity needed for optimal effectiveness, ranging from 1 to 300 activity units per gram or milliliter of composition. Additionally, he has created compositions for cleaning teeth and the oral cavity, which utilize invertase as an active ingredient. This composition stands out for its effectiveness in reducing dental plaque formation and preventing dental caries, showcasing Ishibashi's innovative approach to dental care.

Career Highlights

Throughout his career, Ishibashi has focused on advancing oral hygiene technologies. His role at Sankyo Company, Limited has allowed him to collaborate with leading professionals in the field, fostering an environment of innovation and development. His extensive patent portfolio is a testament to his inventive prowess and dedication to improving dental health.

Collaborations

Keijiro Ishibashi works alongside notable coworkers, including Atsushi Aoki and Rikiya Fukuda. Together, they contribute to a collaborative atmosphere that nurtures creativity and innovation. These partnerships enhance the research and development processes, ensuring that their inventions are grounded in scientific rigor and practical application.

Conclusion

Keijiro Ishibashi stands as a significant figure in dental innovation, with his patents paving the way for enhanced dental care solutions. His unwavering commitment to research and collaboration continues to impact the industry positively, making him an invaluable asset to Sankyo Company, Limited and the broader field of oral health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…